A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)
Clinical trial NCT06687369 · RECRUITING
Trial details
- NCT number
- NCT06687369
- Sponsor
- mAbxience Research S.L.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-30
- Primary completion
- 2026-06-01
- Enrollment
- 726
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.